Table 7 Cost-effectiveness analyses of maternal and serodiscordant partner outcomes in the long-term
Parameters | Option B | Option B+ |
|---|---|---|
Cost | ||
Program Cost (Total 10 years) | US$3,323,647.78 | US$23,488,464.80 |
Maternal outcomes | ||
Number of HIV infected women alive after ten years | 1394 | 1782 |
Number of life-year gained for HIV infected women in ten years | 10,254 | 14,144 |
Number of QALY acquired for HIV infected women in ten years | 9544 | 13,310 |
Serodiscordant transmission outcomes | ||
Serodiscordant partner infections averted | 410 | 3068 |
Cost-effectiveness ratios | ||
Cost per life-year gained | US$324.13 | US$1660.69 |
Cost per QALY acquired | US$348.23 | US$1764.76 |
Cost per serodiscordant partner infection averted | US$8098.99 | US$7655.70 |
ICER per life-year gained(compared to Option B) | US$5183.96 | |
ICER per QALY gained(compared to Option B) | US$5355.42 | |